HERC4 exerts an anti-tumor role through destabilizing the oncoprotein Smo

Area of Science:

• Molecular Biology
• Oncology
• Cell Biology

Background:

• The Hedgehog (Hh) signaling pathway is crucial for development and its hyperactivation is implicated in various cancers, including non-small cell lung cancer (NSCLC).
• Smoothened (Smo) is a key transmembrane protein transducer in the Hh pathway, and its stability is critical for pathway activity.
• The precise mechanisms regulating Smo protein stability remain largely unknown.

Purpose of the Study:

• To elucidate the molecular mechanisms governing Smo protein stability.
• To identify novel regulators of the Hedgehog pathway in the context of cancer.
• To evaluate the potential of HERC4 as a therapeutic target for NSCLC.

Main Methods:

• Modifier screening in Drosophila to identify factors affecting dSmo stability.
• Depletion studies using RNA interference to assess the role of dHerc4/HERC4.
• Western blotting to quantify protein levels of dSmo/Smo and HERC4.
• Immunoprecipitation assays to investigate protein-protein interactions.
• Analysis of HERC4 expression in human NSCLC patient samples.
• Cell proliferation assays in NSCLC cell lines.

Main Results:

• The E3 ligase dHerc4 was identified as a negative regulator of dSmo stability in Drosophila.
• Depletion of dHerc4 led to increased dSmo protein levels and activation of the Hh pathway.
• HERC4 expression is downregulated in NSCLC tissues and inversely correlates with Smo levels.
• HERC4 physically interacts with Smo in human NSCLC cells.
• Knockdown of HERC4 in NSCLC cells resulted in Hh pathway activation and enhanced cell proliferation.

Conclusions:

• HERC4 functions as a tumor suppressor in NSCLC by promoting the degradation of the oncoprotein Smo.
• HERC4 destabilizes Smo, thereby inhibiting Hh pathway signaling and reducing cancer cell proliferation.
• HERC4 represents a promising therapeutic target for the treatment of NSCLC.